证券代码：600186 证券简称：莲花健康 公告编号：2023-041 莲花健康产业集团股份有限公司 关于参加河南辖区上市公司2023年投资者网上集体接待日 活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 为进一步加强与广大投资者的互动交流，莲花健康产业集团股份有限公司 （以下简称"公司"）定于 2023 年 5 月 18 日（周四）16:00-17:20 参加在全 景网举办的"真诚沟通 传递价值"河南辖区上市公司 2023 年投资者网上集体接 待日活动。现将有关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景·路演天下" （http://rs.p5w.net）进入专区页面参与本次互动交流。 出席本次网上集体接待日活动的人员有：公司副总裁兼董事会秘书罗贤辉先 生、财务总监于腾先生、证券事务代表顾友群女士（如有特殊情况，参会人员将 可能进行调整），欢迎广大投资者积极参与。 特此公告。 莲花健康产业集团股份有限公司董事会 2023 年 5 月 13 日 ...

证券代码：600186 证券简称：莲花健康 公告编号：2023-038 莲花健康产业集团股份有限公司 关于召开 2022 年度业绩说明会的公告 投资者可于 2023 年 05 月 09 日(星期二) 至 05 月 15 日(星期 一)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或 通过公司邮箱 lhg@mylotushealth.com 进行提问。公司将在说明会上 对投资者普遍关注的问题进行回答。 莲花健康产业集团股份有限公司（以下简称"公司"）已于 2023 年 3 月 31 日发布公司《公司 2022 年年度报告》及其摘要，为便于广 大投资者更全面深入地了解公司 2022 年度经营成果、财务状况，公 司计划于 2023 年 05 月 16 日 下午 15:00-16:00 举行 2022 年度业绩 说明会，就投资者关心的问题进行交流。 一、 说明会类型 会议召开时间：2023 年 05 月 16 日(星期二) 下午 15:00-16:00 会 议 召 开 地 点 ： 上海证券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http://roadshow.sseinfo.com/） 会 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥455,779,558.55, representing a year-on-year increase of 9.18%[5] - The net profit attributable to shareholders was ¥20,987,154.16, reflecting a significant increase of 43.23% compared to the same period last year[5] - The basic earnings per share for the quarter was ¥0.0117, which is an increase of 46.25% year-on-year[5] - In Q1 2023, the company reported a net profit of CNY 22,037,147.18, an increase of 40.5% compared to CNY 15,668,519.37 in Q1 2022[21] - The total revenue from operating activities was CNY 517,496,855.77, up from CNY 487,993,984.20 in the same period last year, reflecting a growth of 6.5%[24] - The company's operating profit reached CNY 28,440,895.40, representing a 33.5% increase from CNY 21,374,494.15 in the previous year[21] - The total comprehensive income for Q1 2023 was CNY 22,037,147.18, compared to CNY 15,665,631.69 in Q1 2022, reflecting a growth of 40.5%[22] Cash Flow and Assets - The net cash flow from operating activities decreased by 63.59%, amounting to ¥21,583,761.97[5] - The company's cash and cash equivalents as of March 31, 2023, amounted to RMB 1,352,872,179.09, slightly down from RMB 1,379,970,760.49 at the end of 2022[16] - The total assets at the end of the reporting period were ¥2,430,140,831.12, showing a slight increase of 0.11% from the previous year[6] - The total assets of the company as of March 31, 2023, were RMB 2,430,140,831.12, a slight increase from RMB 2,427,357,984.04 at the end of 2022[18] - The company's total assets at the end of Q1 2023 were CNY 608,483,017.48, a decrease from CNY 658,439,367.69 at the end of Q1 2022[26] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 62,636[13] - The top shareholder, Wuhu Lian Tai Investment Management Center, holds 180,509,529 shares, accounting for 10.06% of the total shares[13] - The company repurchased a total of 19,381,400 shares, representing 1.08% of the total share capital[14] Expenses and Liabilities - Total operating costs for Q1 2023 were RMB 427,154,766.87, up from RMB 396,082,288.84 in Q1 2022, reflecting a year-over-year increase of 7.1%[20] - Research and development expenses increased to CNY 3,183,767.55, a rise of 63.3% from CNY 1,948,187.29 in Q1 2022[21] - Sales expenses rose to CNY 24,101,922.87, an increase of 42.0% compared to CNY 16,996,675.14 in the previous year[21] - The total liabilities decreased to RMB 1,241,086,639.18 from RMB 1,249,813,207.06, showing a reduction of 0.7%[18] - The company incurred a financial expense of CNY -3,485,466.02, an improvement from CNY -4,746,494.28 in Q1 2022[21] Other Financial Metrics - The weighted average return on equity increased by 0.44 percentage points to 1.48%[6] - The prepayments increased significantly by 46.84%, indicating higher procurement activity during the period[10] - The company reported a government subsidy of ¥310,500 related to its normal business operations[8] - Accounts receivable increased to RMB 109,041,067.70 from RMB 102,852,835.07, indicating a rise of 6.4%[16] - Inventory levels rose to RMB 84,402,350.18, compared to RMB 74,211,106.40 at the end of 2022, marking a 13.7% increase[16] - The company's equity attributable to shareholders increased to RMB 1,422,934,095.59 from RMB 1,412,474,673.65, reflecting a growth of 0.7%[18] - The company reported a net loss of RMB 1,487,820,903.82, slightly improved from a loss of RMB 1,508,808,057.98 in the previous period[18]

Financial Performance - The company reported a basic earnings per share of CNY 0.03 for 2022, unchanged from 2021, but down from CNY 0.05 in 2020[6]. - The weighted average return on equity decreased to 3.22% in 2022, down 2.23 percentage points from 5.45% in 2021[6]. - The total operating income for the first quarter of 2022 was CNY 417,456,782.99, with a net profit attributable to shareholders of CNY 14,652,986.00[9]. - The company reported a revenue of 1.691 billion yuan, a year-on-year decrease of 6.83%, while the net profit attributable to shareholders increased by 4.06% to 46.1672 million yuan[15]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was 62.363 million yuan, representing a year-on-year growth of 37.82%[15]. - The company achieved operating revenue of CNY 1,691,055,172.21 in 2022, a decrease of 6.83% compared to CNY 1,814,929,608.87 in 2021[30]. - Net profit attributable to shareholders was CNY 46,167,166.21, representing a growth of 4.06% from CNY 44,364,370.77 in the previous year[30]. - The total revenue for the reporting period reached CNY 1,687,035,573.99, an increase from CNY 1,449,822,340.12, representing a growth rate of 14.06%[121]. - The company’s total revenue for the reporting period was approximately ¥1.69 billion, a decrease of 6.78% compared to the previous year[94]. Sales and Market Presence - The company launched new product lines including hot pot base, sauerkraut fish seasoning, and braised sauce series to meet market demand[3]. - The company has established a comprehensive sales network across the country, with a focus on distributor-based sales[4]. - The company achieved a total sales volume of 120,500 tons of monosodium glutamate, 20,400 tons of chicken essence, and 37,600 tons of flour during the reporting period[15]. - The company’s main product, monosodium glutamate, remains a crucial seasoning in the Chinese market, with a high industry concentration following several rounds of consolidation[72]. - The company maintains a leading position in the domestic monosodium glutamate retail market, with its "Lianhua" brand recognized nationwide[127]. - The company plans to enhance its production capabilities for seasoning products, including monosodium glutamate and chicken essence, while developing new healthy seasoning products[127]. - The company has established a presence in over 70 countries and regions, including Europe, Southeast Asia, Central Asia, Africa, and Russia[127]. - The company aims to continuously upgrade its product offerings based on consumer demand, focusing on health-oriented products[127]. Research and Development - The company has increased its investment in new product research and development, collaborating with research institutions to meet evolving consumer preferences[18]. - The total R&D investment for the period was ¥21,557,179.52, accounting for 1.27% of operating revenue[69]. - The number of R&D personnel accounted for 11.46% of the total workforce, with a total of 144 R&D staff[86]. - The company has allocated a budget of 90 million for research and development in new technologies[142]. - Increased investment in research and development is aimed at expanding the product system and adapting to new consumer trends[103]. Operational Efficiency - Sales expenses decreased by 11.66% year-on-year, reflecting improved operational efficiency[18]. - The company reported a significant decrease in sales expenses due to a sharp decline in flour sales revenue[61]. - The net cash flow from operating activities decreased due to reduced cash receipts from sales of flour products[61]. - The company’s investment activities saw a decrease in cash flow due to the completion of the industrial park construction[61]. - The company aims to enhance its core competitiveness through continuous reform of its systems and mechanisms, and by promoting digital transformation to improve operational efficiency[128]. Governance and Compliance - The company has implemented measures to enhance its corporate governance structure and internal control systems, ensuring compliance with relevant laws and regulations[106]. - The governance structure of the company aligns with modern corporate governance standards, ensuring compliance with relevant laws and regulations[133]. - The company has a commitment to enhancing its operational standards and governance levels[109]. - The company has not reported any disputes or objections from board members regarding company matters[200]. - The company has not established any special committees under the board of directors for the reporting period[193]. Future Outlook and Strategy - Future outlook remains positive, with the company projecting a revenue growth of 15% for the next fiscal year[142]. - The company is planning to expand its market presence in overseas regions, targeting a 20% increase in international sales[142]. - Recent mergers and acquisitions are expected to contribute an additional 10% to overall revenue growth in the upcoming year[142]. - The management plans to accelerate the construction of fundraising projects to significantly improve production efficiency and product quality, while reducing production costs[128]. - The company will implement the "521 Brand Revival Strategy" focusing on compound condiments, health foods, and deep processing of agricultural products, aiming to increase sales revenue and enhance brand value[128]. Financial Management - The company has a cash dividend policy that was revised to protect the rights of minority investors, ensuring clarity in profit distribution standards and procedures[165]. - The company has not proposed a cash profit distribution plan despite having positive distributable profits for shareholders[167]. - The total remuneration for all directors, supervisors, and senior management at the end of the reporting period was 703.94 million RMB[154]. - The company reported a pre-tax remuneration of 74.50 million RMB for the president during the reporting period[154].

Financial Performance - The company's operating revenue for Q3 2022 was ¥454,473,519.21, representing a decrease of 5.09% compared to the same period last year[6] - Net profit attributable to shareholders for Q3 2022 was ¥16,906,408.94, an increase of 107.80% year-on-year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥17,693,144.01, up 102.70% from the previous year[6] - Total operating revenue for the first three quarters of 2022 was CNY 1,314,938,470.37, a decrease of 1.3% compared to CNY 1,329,473,254.17 in the same period of 2021[33] - Net profit for the third quarter of 2022 was CNY 50,943,199.09, an increase of 34.8% compared to CNY 37,789,530.07 in the same quarter of 2021[37] - Earnings per share for the third quarter of 2022 were CNY 0.0272, up from CNY 0.0252 in the same period last year, indicating a growth of 7.9%[39] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,331,187,516.49, reflecting a 2.98% increase from the end of the previous year[8] - As of September 30, 2022, the company's total assets amounted to RMB 2,331,187,516.49, an increase from RMB 2,263,654,921.95 at the end of 2021[23] - Total liabilities as of September 30, 2022, were RMB 1,145,153,845.66, compared to RMB 1,093,564,451.21 at the end of 2021, marking an increase of about 4.7%[29] - The company reported a total current liabilities of RMB 1,125,531,262.02, an increase from RMB 1,073,941,867.57 at the end of 2021[29] - The company's total equity attributable to shareholders was CNY 1,419,638,543.69, showing an increase from CNY 1,405,829,828.65 in the previous reporting period[31] Cash Flow - Cash flow from operating activities for the year-to-date was ¥138,595,957.36, showing a 61.18% increase[8] - Cash flow from operating activities for the first three quarters of 2022 was CNY 1,510,958,131.72, an increase of 4.7% compared to CNY 1,442,652,067.22 in the same period of 2021[40] - The net cash flow from operating activities was $138,595,957.36, an increase of 61.1% compared to $85,989,575.12 in the previous period[42] - Total cash inflow from financing activities was $1,046,198,204.59, while cash outflow was $418,262,232.26, resulting in a net cash flow of $627,935,972.33[44] - The cash and cash equivalents at the end of the period amounted to $704,226,049.41, up from $612,186,953.28 at the beginning of the period, reflecting a net increase of $92,039,096.13[44] Inventory and Fixed Assets - The company's inventory decreased by 41.69% due to increased sales of products[15] - The company's fixed assets increased by 44.69% due to the transfer of newly constructed projects[15] - The company's inventory decreased significantly to RMB 53,949,614.07 from RMB 92,524,544.80, representing a decline of approximately 41.7%[27] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 61,854[16] - The largest shareholder, Wuhu Liantai Investment Management Center, held 10.06% of the shares, amounting to 180,509,529 shares[16] Financial Improvements - The company reported a financial expense of CNY -13,598,245.86, a significant improvement compared to CNY 12,431,574.02 in the same period last year[33] - The company experienced a credit impairment loss of CNY 70,229.58, compared to a loss of CNY -101,284.69 in the previous year, indicating a recovery trend[37] - The net cash flow from investment activities was -$31,556,862.23, an improvement from -$57,961,161.18 in the previous period[42] Other Information - The company has not disclosed any significant new product developments or market expansion strategies during the reporting period[22]

Financial Performance - The company's operating revenue for the first half of 2022 was ¥860,464,951.16, representing a 1.16% increase compared to ¥850,616,886.97 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was ¥31,902,305.10, an increase of 11.67% from ¥28,567,873.77 in the previous year[22]. - The net cash flow from operating activities was ¥77,212,819.21, showing a significant increase of 24.58% compared to ¥61,980,209.79 in the same period last year[22]. - The basic earnings per share for the first half of 2022 was ¥0.0178, down 14.01% from ¥0.0207 in the same period last year[23]. - The diluted earnings per share remained at ¥0.0178, consistent with the basic earnings per share, reflecting a decrease of 14.01% year-on-year[23]. - The company reported a net profit after deducting non-recurring gains and losses of ¥31,866,752.72, which is a 14.06% increase from ¥27,938,601.54 in the previous year[22]. - The company reported a net loss of ¥1,523,072,919.09, slightly improved from a loss of ¥1,554,975,224.19 in the previous period[107]. - The total comprehensive income for the first half of 2022 was RMB 33,378,449.43, compared to RMB 29,398,336.60 in the same period of 2021, reflecting an increase of approximately 13.4%[118]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,194,009,801.65, a decrease of 3.08% from ¥2,263,654,921.95 at the end of the previous year[22]. - The total current assets amount to ¥1,455,686,312.53, down from ¥1,518,116,957.13, indicating a decrease of approximately 4.13%[102]. - Total liabilities decreased from ¥1,093,564,451.21 to ¥990,540,881.48, a decline of about 9.4%[107]. - The company's cash and cash equivalents at the end of the reporting period amount to ¥1,179,007,694.25, a decrease from ¥1,205,058,426.11 at the beginning of the period[102]. - Accounts receivable increased to ¥107,304,273.22 from ¥105,517,434.01, indicating a growth of approximately 1.69%[102]. - Inventory decreased to ¥54,195,984.71 from ¥92,524,544.80, reflecting a decline of about 41.2%[102]. - The total cash inflow from operating activities decreased by approximately 23.3% compared to the previous period[137]. Market Position and Strategy - The domestic condiment industry has maintained an average annual compound growth rate of over 15% over the past decade, with a projected revenue growth rate of around 10% over the next five years[31]. - The company has established a comprehensive sales network across the country, with sales representatives in major cities and distribution points in most county-level areas[34]. - The company has a strong brand advantage, recognized as a national trademark strategy demonstration enterprise and awarded multiple quality accolades[35]. - The company is a leading player in the MSG market, which remains a crucial product in China's flavoring market, with a production capacity that peaked at 2.56 million tons[31]. - The company has shifted its MSG business towards semi-finished product processing, primarily producing monosodium glutamate[34]. - The company is focusing on brand building and expanding new sales channels to capture new markets and increase profitability[40]. Research and Development - Research and development expenses increased by 2.66% to 6.33 million RMB, reflecting a commitment to expanding the product range[41]. - The company has a national-level enterprise technology center and has accumulated rich experience in production and technology processes, holding many proprietary technologies[36]. - The company’s product structure includes MSG, chicken essence, and other seasoning products, with a focus on green product development[34]. Legal and Compliance - The company is involved in several ongoing legal disputes, including a case with Henan Lianhua Flavoring Group Co., Ltd. regarding a subrogation dispute, which has been suspended[71]. - The company has not reported any significant litigation or arbitration matters other than those already disclosed[71]. - The company has committed to environmental management by adhering to various environmental protection laws and regulations, ensuring compliance in daily operations[64]. - The company has not disclosed any significant changes in its environmental information or measures taken to reduce carbon emissions during the reporting period[66]. Shareholder Information - Total number of common shareholders as of the end of the reporting period is 62,667[89]. - The largest shareholder, Wuhu Lian Tai Investment Management Center, holds 180,509,529 shares, accounting for 10.06% of total shares[89]. - The company has no significant changes in its share capital structure during the reporting period, with total shares remaining unchanged[85]. - The company has released all restricted shares during the reporting period, totaling 166,666,666 shares from one shareholder and 83,333,333 shares from another[86]. Financial Management - The company has not disclosed any plans for profit distribution or capital reserve transfer during this reporting period[6]. - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties during the reporting period[69]. - The company has not implemented any employee stock ownership plans or other incentive measures during the reporting period[60]. - The company has not reported any major guarantees or leasing matters during the reporting period[82].

证券代码：600186 证券简称：莲花健康 公告编号：2022-020 莲花健康产业集团股份有限公司 关于参加河南辖区上市公司2022年投资者网上集体接待日 | --- | --- | |-------|------------------------------------------------------------------------------| | | 活动的公告 | | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 | | | 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 | 为进一步加强与广大投资者的互动交流，莲花健康产业集团股份有限公司 （以下简称"公司"）定于 2022 年 5 月 30 日（周一）15:30-17:00 参加在全 景网举办的"真诚沟通 传递价值"河南辖区上市公司 2022 年投资者网上集体接 待日活动。现将有关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景·路演天下" （http://rs.p5w.net）进入专区页面参与本次互动交流。 出席本次网上集体接待日活动的人员有：公司总裁曹家胜先生、副总 ...

Financial Performance - The company's operating revenue for 2021 was CNY 1,814,929,608.87, representing a 9.69% increase compared to CNY 1,654,638,589.14 in 2020[20]. - The net profit attributable to shareholders for 2021 was CNY 44,364,370.77, a decrease of 40.28% from CNY 74,286,138.33 in 2020[20]. - Basic earnings per share for 2021 were CNY 0.03, down 40.00% from CNY 0.05 in 2020[21]. - The weighted average return on equity decreased to 5.45% in 2021, down from 21.34% in 2020, a decline of 15.89 percentage points[21]. - The total revenue for the reporting period was CNY 1,809,698,398.51, with a gross profit margin of 12.36%, reflecting a decrease of 5.42 percentage points compared to the previous year[60]. - The company reported a total comprehensive income of CNY 42,931,758.16 for 2021, compared to CNY 76,942,546.27 in 2020[189]. Cash Flow and Assets - The net cash flow from operating activities improved to CNY 70,048,794.63 in 2021, compared to a negative cash flow of CNY -794,229,165.46 in 2020[20]. - Cash and cash equivalents at the end of the period amounted to CNY 1,205,058,426.11, representing 53.24% of total assets, up from 31.29% in the previous period[53]. - The company's total assets increased by 50.53% to CNY 2,263,654,921.95 at the end of 2021, up from CNY 1,503,783,979.79 in 2020[20]. - The total liabilities decreased to CNY 1,093,564,451.21 in 2021 from CNY 1,352,823,471.80 in 2020, a reduction of approximately 19.2%[181]. - The total equity attributable to shareholders increased to CNY 1,405,829,828.65 in 2021 from CNY 385,307,198.86 in 2020, reflecting a growth of approximately 264.5%[181]. Sales and Market Performance - The company sold 118,600 tons of monosodium glutamate, 25,300 tons of chicken essence, and 121,200 tons of flour in 2021, resulting in a total sales revenue of RMB 1.815 billion, a year-on-year increase of 9.69%[28]. - The company achieved a sales revenue of 1.815 billion RMB, representing a year-on-year growth of 9.69%[36]. - The domestic condiment industry has maintained a compound annual growth rate of over 15% over the past decade, with a projected growth rate of around 10% for the next five years[31]. - The company has established a comprehensive sales network across the country, with sales representatives in major cities and a presence in most county-level areas[32]. Research and Development - R&D expenses increased by 24.56% year-on-year to RMB 22.07 million, focusing on developing new health-oriented seasoning products and enhancing product innovation[29]. - The total R&D expenditure for the period was ¥22,072,411.15, accounting for 1.22% of the operating revenue[49]. - The company will continue to increase R&D investment, focusing on developing new products that align with modern consumer trends, including "recipe-style compound seasonings" and various sauces[71]. Corporate Governance and Management - The company held 9 supervisory board meetings during the reporting period, ensuring compliance with legal and regulatory requirements[78]. - A fair and transparent performance evaluation and incentive mechanism for senior management has been established, aligning with relevant laws and regulations[78]. - The company has committed to continuous improvement in corporate governance and internal control mechanisms to promote healthy development[79]. - The company has established specialized committees under the board, including the audit, nomination, compensation, and strategic committees[102]. Market Risks and Challenges - The company faces market risks due to increasing competition and consumer demands for product quality, which could impact customer retention and performance[74]. - The company recognizes the challenge of attracting and retaining high-end talent amid increasing competition and rising labor costs[74]. - The company has outlined various risk factors in the report, which investors should be aware of[7]. Future Outlook and Strategy - The company plans to enhance its production capacity for seasoning products, including MSG, chicken essence, and compound seasonings, while also developing new healthy seasoning products and foods[68]. - In 2022, the company aims to complete the relocation to a new factory and initiate the second phase of the new area project, which is expected to enhance production capacity and increase revenue scale[70]. - The company plans to continue expanding its market presence and exploring new strategies for growth[154].

Financial Performance - The company's operating revenue for Q1 2022 was ¥417,456,782.99, representing a year-on-year increase of 0.72%[6] - The net profit attributable to shareholders for Q1 2022 was ¥14,652,986.00, showing a significant increase of 32.80% compared to the same period last year[6] - The net cash flow from operating activities reached ¥59,271,724.69, marking a substantial increase of 246.73% year-on-year[6] - The basic earnings per share for Q1 2022 was ¥0.008, unchanged from the previous year[9] - Operating profit for Q1 2022 was CNY 21,374,494.15, up from CNY 19,007,701.82 in Q1 2021, reflecting an increase of approximately 12.5%[27] - Net profit for Q1 2022 reached CNY 15,668,519.37, compared to CNY 12,074,523.10 in Q1 2021, marking a growth of around 30.0%[29] - The net profit attributable to shareholders of the parent company was CNY 14,652,986.00 in Q1 2022, an increase from CNY 11,033,820.63 in Q1 2021, representing a growth of approximately 32.5%[29] - The total comprehensive income for Q1 2022 was CNY 15,665,631.69, compared to CNY 12,074,523.10 in Q1 2021, showing an increase of approximately 30.0%[29] Assets and Liabilities - The total assets at the end of Q1 2022 were ¥2,216,633,686.30, a decrease of 2.08% from the end of the previous year[9] - Total current assets amounted to ¥1,472,214,449.25, a decrease from ¥1,518,116,957.13 as of December 31, 2021, reflecting a decline of approximately 3%[18] - Total assets as of March 31, 2022, were ¥2,216,633,686.30, down from ¥2,263,654,921.95 at the end of 2021, a decrease of about 2.1%[21] - Total current liabilities decreased to ¥1,011,253,556.38 from ¥1,073,941,867.57, reflecting a reduction of approximately 5.8%[21] - The company’s total liabilities decreased to ¥1,755,672,793.43 from ¥1,817,453,832.39, reflecting a decline of approximately 3.4%[21] - Total liabilities amounted to CNY 1,030,876,140.03, a decrease from CNY 1,093,564,451.21 in the previous period, indicating a reduction of about 5.7%[23] - Total equity attributable to shareholders of the parent company was CNY 1,420,481,370.81, up from CNY 1,405,829,828.65, reflecting an increase of approximately 1.0%[23] Cash Flow - Cash inflow from operating activities for Q1 2022 was approximately $487.99 million, an increase from $471.57 million in Q1 2021, representing a growth of about 3.0%[32] - The net cash flow from operating activities for Q1 2022 was approximately $59.27 million, significantly higher than $17.09 million in Q1 2021, marking an increase of about 247.0%[32] - Cash received from tax refunds in Q1 2022 was approximately $12.74 million, compared to $1.94 million in Q1 2021, indicating a growth of about 558.0%[32] - The total cash and cash equivalents at the end of Q1 2022 amounted to approximately $663.18 million, up from $58.07 million at the end of Q1 2021, reflecting a substantial increase[34] - The net increase in cash and cash equivalents for Q1 2022 was approximately $46.25 million, compared to $11.82 million in Q1 2021, indicating a significant improvement[34] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 66,560[12] - The largest shareholder, Wuhu Liantai Investment Management Center, held 10.06% of the shares, totaling 180,509,529 shares[12] Operational Efficiency - The company experienced a significant increase in net profit due to changes in financing structure and a substantial decrease in financial expenses[11] - The company reported a decrease in sales expenses to CNY 16,996,675.14 in Q1 2022 from CNY 25,925,147.69 in Q1 2021, a reduction of about 34.5%[27] - Research and development expenses for Q1 2022 were CNY 1,948,187.29, slightly up from CNY 1,910,415.28 in Q1 2021, indicating a growth of around 2.0%[27] Inventory and Receivables - Accounts receivable decreased to ¥101,052,966.14 from ¥105,517,434.01, indicating a reduction of about 4.4%[18] - Inventory decreased significantly from ¥92,524,544.80 to ¥52,295,267.74, representing a decline of approximately 43.5%[18] Government Support - The company received government subsidies amounting to ¥55,445.59, which are closely related to its normal business operations[11] Product Development - The company has not reported any significant new product developments or market expansions during the reporting period[16]

Financial Performance - The company's operating revenue for Q3 2021 was ¥478,856,367.20, representing a year-over-year increase of 12.14%[5] - The net profit attributable to shareholders for Q3 2021 was ¥8,136,005.89, a decrease of 61.63% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥8,728,752.83, down 54.94% year-over-year[5] - Basic earnings per share for Q3 2021 were ¥0.0085, a decline of 44.71% compared to the previous year[7] - The diluted earnings per share for Q3 2021 were also ¥0.0085, reflecting a 44.71% decrease year-over-year[7] - The weighted average return on equity for Q3 2021 was 0.90%, a decrease of 5.11 percentage points from the previous year[7] - Total operating revenue for the first three quarters of 2021 reached ¥1,329,473,254.17, an increase from ¥1,209,529,582.00 in the same period of 2020, representing a growth of approximately 9.9%[29] - The net profit attributable to shareholders of the parent company for Q3 2021 was ¥36,703,879.66, compared to ¥52,333,114.38 in Q3 2020, reflecting a decrease of approximately 30%[32] - Total comprehensive income amounted to CNY 37,789,530.07 for the current period, compared to CNY 54,674,834.86 in the previous period, reflecting a decrease of approximately 30.8%[34] - Basic and diluted earnings per share were CNY 0.0252, down from CNY 0.0379 in the previous period, indicating a decline of about 33.5%[34] Assets and Liabilities - Total assets at the end of Q3 2021 amounted to ¥2,254,284,037.45, an increase of 49.91% compared to the end of the previous year[7] - The company's total assets as of September 30, 2021, amounted to approximately RMB 2.25 billion, an increase from RMB 1.50 billion at the end of 2020[20] - The company's total liabilities decreased to ¥1,089,335,794.80 in Q3 2021 from ¥1,352,823,471.80 in Q3 2020, a reduction of about 19.5%[29] - The equity attributable to shareholders at the end of Q3 2021 was ¥1,398,169,283.11, up 262.87% from the previous year[7] - The total equity attributable to shareholders of the parent company increased to ¥1,398,169,283.11 in Q3 2021 from ¥385,307,198.86 in Q3 2020, showing a significant increase of approximately 263%[29] Cash Flow - The company reported a cash flow from operating activities of ¥85,989,575.12 for the year-to-date period[5] - Cash inflow from operating activities totaled CNY 1,470,949,767.01, an increase from CNY 1,296,802,065.12, representing a growth of approximately 13.4%[38] - Cash outflow from operating activities decreased to CNY 1,384,960,191.89 from CNY 2,047,860,548.96, showing a reduction of about 32.3%[38] - Net cash flow from operating activities was CNY 85,989,575.12, a significant improvement compared to a net outflow of CNY -751,058,483.84 in the previous period[38] - Cash inflow from financing activities reached CNY 1,046,198,204.59, a substantial increase from CNY 50,450,000.00 in the previous period[39] - Net cash flow from financing activities was CNY 627,935,972.33, compared to a net outflow of CNY -215,359,217.35 in the previous period, indicating a turnaround[39] - The ending balance of cash and cash equivalents was CNY 702,205,776.24, a significant increase from CNY 40,397,350.87 in the previous period[39] - The company reported a cash inflow of CNY 8,252,635.25 from tax refunds, up from CNY 4,581,719.77 in the previous period, marking an increase of approximately 80.5%[38] - Cash outflow for employee compensation was CNY 95,132,059.91, a decrease from CNY 839,812,043.38 in the previous period, reflecting a reduction of about 88.7%[38] Shareholder Information - The total number of common shareholders at the end of the reporting period was 57,167[16] - The largest shareholder, Wuhu Liantai Investment Management Center, holds 180,509,529 shares, representing 10.06% of total shares[16] Operational Challenges - The increase in raw material procurement prices exceeded the increase in product sales prices, impacting the gross profit margin negatively[12] Research and Development - Research and development expenses for Q3 2021 were ¥9,636,221.63, a substantial increase from ¥1,275,219.95 in Q3 2020, representing a growth of about 655%[29] Future Outlook - The company plans to continue focusing on market expansion and new product development to drive future growth[30]